Answer to Mungmunpuntipantip et al. "SARS CoV-2 vaccine AND rituximab" Joint Bone Spine 2021;88:105281.

Verhoeven, Frank; Lepiller, Quentin; Hecquet, Sophie; Prati, Clément; Wendling, Daniel

Verhoeven, Frank; Lepiller, Quentin; Hecquet, Sophie; Prati, Clément; Wendling, Daniel.

Verhoeven F; Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France; EA 4267 "PEPITE", UFR Santé, Franche-Comté University, 19, rue Ambroise Paré, bâtiment S, 25030 Besançon cedex, France. Electronic address: fverhoeven@chu-besancon.fr.
Lepiller Q; Virology laboratory, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France.
Hecquet S; Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France.
Prati C; Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France; EA 4267 "PEPITE", UFR Santé, Franche-Comté University, 19, rue Ambroise Paré, bâtiment S, 25030 Besançon cedex, France.
Wendling D; Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France; EA 4266 « EPILAB ¼, UFR Santé, Franche-Comté University, 19, rue Ambroise Paré, bâtiment S, 25030 Besançon cedex, France.

Joint Bone Spine ; 89(1): 105283, 2022 01.

Article in English | MEDLINE | ID: covidwho-1446797

Subject(s)

COVID-19; Severe Acute Respiratory Syndrome; COVID-19 Vaccines; Humans; Rituximab; SARS-CoV-2

Keywords

COVID; Rituximab; Vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe Acute Respiratory Syndrome / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Joint Bone Spine Journal subject: Rheumatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google